I never thought about connecting those dots... King Charles III was diagnosed with cancer in February 2024, following tests after a procedure for an enlarged prostate. While the exact details of his treatment have not been publicly disclosed, he has been receiving ongoing medical care, and in March 2025, he was briefly hospitalized due to side effects before resuming his duties.
Yes, it is possible. NHS recognized DCVax-L’s efficacy against cancer and 'commissioned' it with an IFR requirement, making it available for the King. The King could have played a role in broadening the indication from GBM to cancer, allowing more patients to benefit. While I'd like to believe that healthcare decisions remain purely equitable, history has shown that special circumstances can drive policy shifts—sometimes opening doors for others in the process.
Of course, all of this remains speculation. But what is NOT speculation is that NHS, by placing DCVax-L on the HCD list, formally validated its safety, efficacy, and significant value—justifying the allocation of limited taxpayer funds for its use. No one with integrity can refute or trivialize that validation (though, inevitably, some FUDsters will try).
NWBO is destined for greatness, and we are positioned ahead of the inevitable rush—what a privilege to witness this unfold and profit from it.
Market Data 
Markets 
